Tracheobronchial stenosis as a rare extraintestinal manifestation of ulcerativecolitis: a case series with different therapeutic approaches - Top-Institutions - MDSpire

Tracheobronchial stenosis as a rare extraintestinal manifestation of ulcerativecolitis: a case series with different therapeutic approaches

  • By

  • Zanini, Umberto

  • Franco, Giovanni

  • Mazzotta, Sofia Maria

  • geroli, luca

  • bono, francesca

  • paciocco, giuseppe

  • Faverio, Paola

  • Luppi, Fabrizio

  • marruchella, almerico

  • May 25, 2026

  • 0 min

Share

Top Institutions in Pulmonary

Brief introduction explaining scope and methodology.

  • #1

    Mayo Clinic
    Mayo Clinic

    Rochester, Minnesota

    Key Differentiators

    • Gastroenterology
    • Pulmonary Medicine

  • #2

    Cleveland Clinic
    Cleveland Clinic

    Cleveland, Ohio

    Key Differentiators

    • Gastroenterology
    • Pulmonary Medicine

  • #3

    University Clinical Hospital No. 4
    University Clinical Hospital No. 4

    Poznan, Poland

    Key Differentiators

    • Gastroenterology

  • #4

    Xinhua Hospital Affiliated with the Medical School of Shanghai Jiaotong University
    Xinhua Hospital Affiliated with the Medical School of Shanghai Jiaotong University

    Shanghai, China

    Key Differentiators

    • Gastroenterology

  • #5

    Poznan University of Medical Sciences
    Poznan University of Medical Sciences

    Poznan, Poland

    Key Differentiators

    • Gastroenterology

Original Source(s)

Tracheobronchial stenosis as a rare extraintestinal manifestation of ulcerativecolitis: a case series with different therapeutic approaches

  • by Zanini, Umberto , Franco, Giovanni , Mazzotta, Sofia Maria, geroli, luca , bono, francesca , paciocco, giuseppe , Faverio, Paola , Luppi, Fabrizio , marruchella, almerico

  • May 25, 2026

Related Content

Evaluation of Muscle Mass from Chest CT versus Body Mass Index in Determining Severity and Outcomes in Non-Cystic Fibrosis Bronchiectasis

FDA Expands Afrezza to Pediatric Diabetes

The decision was supported by the phase 3 INHALE-1 trial and additional long-term safety, efficacy, and exposure data.

Curbing Drug-Related Halitosis for Closer Moments

Individuals who have drug-related halitosis may need to take additional steps to prioritize oral health before intimate encounters.